The challenges of innovative therapeutic interventions in hemophilia
Louis M. Aledort
Acquired TTP: are we ready for a prognosis-dependent management?
Hemolytic uremic syndrome (HUS)
The most recent advances in aHUS and TTP including complement and VWFcomplement interactions.
G. Remuzzi, M. Noris
Von Willebrand factor
Collagen and VWF interactions and beyond
Veronica Flood, Robert R. Montgomery
The genetics of von Willebrand disease, to include recent developments from ourselves and others.
Anne C. Goodeve
The potential use of nanobodies in the treatment of VWD and hemophilia
Peter J. Lenting
Determinants of FVIII inhibitor risk: Is VWF a key factor?
David P. Lillicrap
VWF regulation of blood vessel formation and function
Anna M. Randi
Old concepts and new functions of von Willebrand factor: 2017
Zaverio M. Ruggeri
Autoantibody development in acquired TTP
… more preliminary topics soon on line, stay tuned!